SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-025105
Filing Date
2019-05-10
Accepted
2019-05-10 09:45:29
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv520788_10q.htm 10-Q 293932
2 EXHIBIT 31.1 tv520788_ex31-1.htm EX-31.1 9879
3 EXHIBIT 31.2 tv520788_ex31-2.htm EX-31.2 9883
4 EXHIBIT 32.1 tv520788_ex32-1.htm EX-32.1 5089
5 EXHIBIT 99.1 tv520788_ex99-1.htm EX-99.1 54183
6 GRAPHIC tv520788_img1.jpg GRAPHIC 30316
7 GRAPHIC logo.jpg GRAPHIC 1982
  Complete submission text file 0001144204-19-025105.txt   3724881

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT fenc-20190331.xml EX-101.INS 1097877
9 XBRL TAXONOMY EXTENSION SCHEMA fenc-20190331.xsd EX-101.SCH 31815
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fenc-20190331_cal.xml EX-101.CAL 20915
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fenc-20190331_def.xml EX-101.DEF 176902
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE fenc-20190331_lab.xml EX-101.LAB 208696
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fenc-20190331_pre.xml EX-101.PRE 202381
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 19813133
SIC: 2836 Biological Products, (No Diagnostic Substances)